{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:43:14Z","timestamp":1776728594132,"version":"3.51.2"},"posted":{"date-parts":[[2026,2,13]]},"group-title":"In Review","reference-count":43,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,1,6]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  <bold>Background:<\/bold>\n                  Overdose deaths involving illicitly manufactured fentanyl have risen sharply, particularly among young people, who are increasing exposed to counterfeit pills. While much is known about adult populations, little research explores how young people perceive and respond to the risks of fentanyl.\n                  <bold>Methods:<\/bold>\n                  From October 2023 to March 2024, we conducted semi-structured interviews with 21 young people in Oregon (ages 15 to 25) who had reported lifetime use of non-prescription pills. Interviews explored knowledge, experiences, risk reduction practices, and trusted information sources related to fentanyl and counterfeit pills. Transcripts were analyzed using thematic analysis.\n                  <bold>Results:<\/bold>\n                  Participants demonstrated broad awareness of the dangers of fentanyl and counterfeit pills and described fentanyl as potent, lethal, and increasingly prevalent. Knowledge varied, however, with some holding misconceptions (e.g., risk of overdose from touch). Participants reported practicing risk reduction strategies, including avoiding pills of uncertain sources, using fentanyl test strips, carrying naloxone, and monitoring peers\u2019 safety. Barriers such as limited access to resources, inconsistent availability of drug checking tools, and stigma constrained their ability to reduce risk. Participants described strong peer-to-peer networks that emphasized safety and mutual support. Finally, participants expressed a desire for accurate, fact-based, nonjudgmental education about fentanyl and drug use. They emphasized the importance of schools, parents, and public health organizations providing open dialogue, risk reduction information, and accessible supports such as mental health services, hotlines, and treatment.\n                  <bold>Conclusion:<\/bold>\n                  Young people in Oregon who have used non-prescription pills are aware of fentanyl\u2019s presence in the drug supply and are motivated to stay safe but encounter barriers that limit their ability to consistently practice risk reduction. Tailored, age-specific interventions that build on existing peer-to-peer networks and expand access to risk reduction resources\u2014including naloxone, fentanyl test strips, and fact-based education\u2014are urgently needed to reduce overdose risk and support young people\u2019s wellbeing.\n                <\/p>","DOI":"10.21203\/rs.3.rs-8534564\/v1","type":"posted-content","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T06:44:59Z","timestamp":1770965099000},"source":"Crossref","is-referenced-by-count":0,"title":["\u201cExtremely cheap and extremely potent\u201d: Fentanyl Knowledge and Risk Practices AmongYoung People in Oregon Who Have Used Non-Prescription Pills"],"prefix":"10.21203","author":[{"given":"Danielle","family":"Good","sequence":"first","affiliation":[{"name":"Comagine Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah S.","family":"Shin","sequence":"additional","affiliation":[{"name":"Comagine Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyn","family":"Kappesser","sequence":"additional","affiliation":[{"name":"Comagine Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Stack","sequence":"additional","affiliation":[{"name":"Comagine Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carson","family":"Deahl","sequence":"additional","affiliation":[{"name":"Comagine Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney","family":"Fultineer","sequence":"additional","affiliation":[{"name":"Oregon Health Authority, Injury and Violence Prevention Program, Public Health Division"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith M.","family":"Leahy","sequence":"additional","affiliation":[{"name":"Oregon Health Authority, Behavioral Health Division"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Todd","family":"Korthuis","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of General Internal Medicine, Section of Addiction Medicine, Oregon Health & Science University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"426","key":"ref1","first-page":"1","article-title":"Drug Overdose Deaths in the United States, 1999\u20132020","author":"Hedegaard H","year":"2021","unstructured":"Hedegaard H, Mini\u00f1o AM, Spencer MR, Warner M. Drug Overdose Deaths in the United States, 1999\u20132020. NCHS Data Brief. 2021(426):1\u20138.","journal-title":"NCHS Data Brief"},{"key":"ref2","volume-title":"Monitoring the Future national survey results on drug use, 1975\u20132022: Secondary school students","author":"Miech RA","year":"2023","unstructured":"Miech RA, Johnston LD, Patrick ME, O\u2019Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future national survey results on drug use, 1975\u20132022: Secondary school students. Monitoring the Future Monograph Series. Ann Arbor, MI: Institute for Social Research, University of Michigan; 2023."},{"key":"ref3","volume-title":"Key substance use and mental health indicators in the United States: Results from the 2020 National Survey on Drug Use and Health","author":"Substance Abuse and Mental Health Services Administration","year":"2021","unstructured":"Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: Results from the 2020 National Survey on Drug Use and Health. Rockville, MD: Center for Behavioral Health Statistics and Quality; 2021."},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-022-00634-4","article-title":"They say it\u2019s fentanyl, but they honestly look like Perc 30s: Initiation and use of counterfeit fentanyl pills","volume":"19","author":"Daniulaityte R","year":"2022","unstructured":"Daniulaityte R, Sweeney K, Ki S, Doebbeling BN, Mendoza N. They say it\u2019s fentanyl, but they honestly look like Perc 30s: Initiation and use of counterfeit fentanyl pills. Harm Reduct J. 2022;19(1):1\u20139.","journal-title":"Harm Reduct J"},{"issue":"48","key":"ref5","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.15585\/mmwr.mm7348a2","article-title":"Detection of Illegally Manufactured Fentanyls and Carfentanil in Drug Overdose Deaths - United States, 2021\u20132024","volume":"73","author":"Tanz LJ","year":"2024","unstructured":"Tanz LJ, Stewart A, Gladden RM, Ko JY, Owens L, O'Donnell J. Detection of Illegally Manufactured Fentanyls and Carfentanil in Drug Overdose Deaths - United States, 2021\u20132024. MMWR Morb Mortal Wkly Rep. 2024;73(48):1099\u2013105. 10.15585\/mmwr.mm7348a2.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref6","author":"Glidden E","year":"2024","unstructured":"Glidden E, Gladden RM, Dion C, Spyres MB, Seth P, Aldy K, et al. MMWR Morb Mortal Wkly Rep. 2024;73(29):642\u20137. 10.15585\/mmwr.mm7329a2. Suspected Counterfeit M-30 Oxycodone Pill Exposures and Acute Withdrawals Reported from a Single Hospital - Toxicology Investigators Consortium Core Registry, U.S. Census Bureau Western Region, 2017\u20132022."},{"issue":"1","key":"ref7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.drugpo.2014.07.013","article-title":"High risk and little knowledge: overdose experiences and knowledge among young adult nonmedical prescription opioid users","volume":"26","author":"Frank D","year":"2015","unstructured":"Frank D, Mateu-Gelabert P, Guarino H, Bennett A, Wendel T, Jessell L, et al. High risk and little knowledge: overdose experiences and knowledge among young adult nonmedical prescription opioid users. Int J Drug Policy. 2015;26(1):84\u201391. 10.1016\/j.drugpo.2014.07.013.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"ref8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12954-017-0206-6","article-title":"Knowledge and possession of take-home naloxone kits among street-involved youth in a Canadian setting: a cohort study","volume":"14","author":"Goldman-Hasbun J","year":"2017","unstructured":"Goldman-Hasbun J, DeBeck K, Buxton JA, Nosova E, Wood E, Kerr T. Knowledge and possession of take-home naloxone kits among street-involved youth in a Canadian setting: a cohort study. Harm Reduct J. 2017;14(1):79. 10.1186\/s12954-017-0206-6.","journal-title":"Harm Reduct J"},{"key":"ref9","author":"Alper J","year":"2024","unstructured":"Alper J, Dawson EP, Norris SMP. Harm Reduction Services for People Who Use Drugs. 2024."},{"issue":"14","key":"ref10","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1001\/jama.2022.2847","article-title":"Trends in Drug Overdose Deaths Among US Adolescents, January 2010 to June 2021","volume":"327","author":"Friedman J","year":"2022","unstructured":"Friedman J, Godvin M, Shover CL, Gone JP, Hansen H, Schriger DL. Trends in Drug Overdose Deaths Among US Adolescents, January 2010 to June 2021. JAMA. 2022;327(14):1398\u2013400. 10.1001\/jama.2022.2847.","journal-title":"JAMA"},{"issue":"Suppl 2","key":"ref11","doi-asserted-by":"publisher","first-page":"S240","DOI":"10.1542\/peds.2020-023523G","article-title":"Principles of Harm Reduction for Young People Who Use Drugs","volume":"147","author":"Kimmel SD","year":"2021","unstructured":"Kimmel SD, Gaeta JM, Hadland SE, Hallett E, Marshall BDL. Principles of Harm Reduction for Young People Who Use Drugs. Pediatrics. 2021;147(Suppl 2):S240\u20138. 10.1542\/peds.2020-023523G.","journal-title":"Pediatrics"},{"key":"ref12","volume-title":"Reducing Opioid Overdose and Misuse: Opioid Overdose and Misuse Resources","author":"Oregon Health Authority","unstructured":"Oregon Health Authority. Reducing Opioid Overdose and Misuse: Opioid Overdose and Misuse Resources. Oregon: Oregon Health Authority."},{"key":"ref13","volume-title":"Oregon overdose deaths are down, CDC data shows","author":"Oregon Health Authority","year":"2025","unstructured":"Oregon Health Authority. Oregon overdose deaths are down, CDC data shows. Oregon: Oregon Health Authority; 2025."},{"key":"ref14","unstructured":"Oregon Health Authority PHD. Opioids and the Ongoing Drug Overdose Crisis in Oregon: Report to the Legislature. Portland, OR2022."},{"key":"ref15","volume-title":"Awareness and Behaviors Related to Pill Use and Fentanyl: Perspectives from Youth and Young Adults in Oregon","author":"Stack E","unstructured":"Stack E, Shin SS, Yoo J, Deahl CC, Gray M, Leichtling G et al. Awareness and Behaviors Related to Pill Use and Fentanyl: Perspectives from Youth and Young Adults in Oregon. Health Promotion Practice. Under Review."},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh ML","year":"2012","unstructured":"McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22(3):276\u201382.","journal-title":"Biochem Med (Zagreb)"},{"key":"ref17","volume-title":"Dramatic increases in opioid overdose deaths due to fentanyl among young people in Washington State","author":"Banta-Green C","year":"2021","unstructured":"Banta-Green C, Williams J. Dramatic increases in opioid overdose deaths due to fentanyl among young people in Washington State. Seattle, WA: Addictions, Drug & Alcohol Institute, University of Washington; 2021."},{"key":"ref18","doi-asserted-by":"publisher","author":"Spencer MR","unstructured":"Spencer MR, Garnett MF, Mini\u02dcno AM. Drug overdose deaths in the United States, 2002\u20132022. National Center for Health Statistics. 2024;NCHS Data Brief, no 491. 10.15620\/cdc:135849","DOI":"10.15620\/cdc:135849"},{"issue":"13","key":"ref19","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1080\/10826084.2022.2120365","article-title":"Fentanyl in Pressed Oxycodone Pills: A Qualitative Analysis of Online Community Experiences with an Emerging Drug Trend","volume":"57","author":"Arya S","year":"2022","unstructured":"Arya S, Nagappala S, Krawczyk N, Gi Y, Meacham MC, Bunting AM. Fentanyl in Pressed Oxycodone Pills: A Qualitative Analysis of Online Community Experiences with an Emerging Drug Trend. Subst Use Misuse. 2022;57(13):1940\u20135. 10.1080\/10826084.2022.2120365.","journal-title":"Subst Use Misuse"},{"issue":"1","key":"ref20","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/S2468-2667(24)00273-1","article-title":"The public health risks of counterfeit pills","volume":"10","author":"Friedman J","year":"2025","unstructured":"Friedman J, Ciccarone D. The public health risks of counterfeit pills. Lancet Public Health. 2025;10(1):e58\u201362. 10.1016\/S2468-2667(24)00273-1.","journal-title":"Lancet Public Health"},{"key":"ref21","article-title":"Drug overdose deaths with evidence of counterfeit pill use\u2014United States, July 2019\u2013December 2021","volume":"72","author":"O\u2019Donnell J","year":"2023","unstructured":"O\u2019Donnell J. Drug overdose deaths with evidence of counterfeit pill use\u2014United States, July 2019\u2013December 2021. MMWR Morbidity Mortal Wkly Rep. 2023;72.","journal-title":"MMWR Morbidity Mortal Wkly Rep"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.drugpo.2018.09.009","article-title":"Use of rapid fentanyl test strips among young adults who use drugs","volume":"61","author":"Krieger MS","year":"2018","unstructured":"Krieger MS, Goedel WC, Buxton JA, Lysyshyn M, Bernstein E, Sherman SG, et al. Use of rapid fentanyl test strips among young adults who use drugs. Int J Drug Policy. 2018a;61:52\u20138. 10.1016\/j.drugpo.2018.09.009.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"ref23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12954-018-0213-2","article-title":"High willingness to use rapid fentanyl test strips among young adults who use drugs","volume":"15","author":"Krieger MS","year":"2018","unstructured":"Krieger MS, Yedinak JL, Buxton JA, Lysyshyn M, Bernstein E, Rich JD, et al. High willingness to use rapid fentanyl test strips among young adults who use drugs. Harm Reduct J. 2018b;15(1):7. 10.1186\/s12954-018-0213-2.","journal-title":"Harm Reduct J"},{"issue":"1","key":"ref24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-017-0205-7","article-title":"Music festival attendees' illicit drug use, knowledge and practices regarding drug content and purity: a cross-sectional survey","volume":"15","author":"Day N","year":"2018","unstructured":"Day N, Criss J, Griffiths B, Gujral SK, John-Leader F, Johnston J, et al. Music festival attendees' illicit drug use, knowledge and practices regarding drug content and purity: a cross-sectional survey. Harm Reduct J. 2018;15(1):1. 10.1186\/s12954-017-0205-7.","journal-title":"Harm Reduct J"},{"issue":"1","key":"ref25","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1080\/07853890.2022.2104922","article-title":"Addressing adolescent substance use with a public health prevention framework: the case for harm reduction","volume":"54","author":"Winer JM","year":"2022","unstructured":"Winer JM, Yule AM, Hadland SE, Bagley SM. Addressing adolescent substance use with a public health prevention framework: the case for harm reduction. Ann Med. 2022;54(1):2123\u201336. 10.1080\/07853890.2022.2104922.","journal-title":"Ann Med"},{"issue":"12","key":"ref26","doi-asserted-by":"publisher","first-page":"e22411","DOI":"10.2196\/22411","article-title":"Reasons People Who Use Opioids Do Not Accept or Carry No-Cost Naloxone: Qualitative Interview Study","volume":"4","author":"Bennett AS","year":"2020","unstructured":"Bennett AS, Freeman R, Des Jarlais DC, Aronson ID. Reasons People Who Use Opioids Do Not Accept or Carry No-Cost Naloxone: Qualitative Interview Study. JMIR Form Res. 2020;4(12):e22411. 10.2196\/22411.","journal-title":"JMIR Form Res"},{"issue":"1","key":"ref27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13722-022-00359-6","article-title":"The system always undermined what I was trying to do as an individual: identifying opportunities to improve the delivery of opioid use services for youth from the perspective of service providers in four communities across British Columbia, Canada","volume":"18","author":"Marchand K","year":"2023","unstructured":"Marchand K, Turuba R, Katan C, Fogarty O, Fairbank J, Tallon C, et al. The system always undermined what I was trying to do as an individual: identifying opportunities to improve the delivery of opioid use services for youth from the perspective of service providers in four communities across British Columbia, Canada. Addict Sci Clin Pract. 2023;18(1):1. 10.1186\/s13722-022-00359-6.","journal-title":"Addict Sci Clin Pract"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.drugpo.2018.02.013","article-title":"Harnessing the language of overdose prevention to advance evidence-based responses to the opioid crisis","volume":"55","author":"Collins AB","year":"2018","unstructured":"Collins AB, Bluthenthal RN, Boyd J, McNeil R. Harnessing the language of overdose prevention to advance evidence-based responses to the opioid crisis. Int J Drug Policy. 2018;55:77\u20139. 10.1016\/j.drugpo.2018.02.013.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.drugpo.2014.04.019","article-title":"Assembling the dominant accounts of youth drug use in Australian harm reduction drug education","volume":"25","author":"Farrugia A","year":"2014","unstructured":"Farrugia A. Assembling the dominant accounts of youth drug use in Australian harm reduction drug education. Int J Drug Policy. 2014;25(4):663\u201372.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"ref30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12954-017-0159-9","article-title":"Social-structural factors influencing periods of injection cessation among marginalized youth who inject drugs in Vancouver, Canada: an ethno-epidemiological study","volume":"14","author":"Boyd J","year":"2017","unstructured":"Boyd J, Fast D, Hobbins M, McNeil R, Small W. Social-structural factors influencing periods of injection cessation among marginalized youth who inject drugs in Vancouver, Canada: an ethno-epidemiological study. Harm Reduct J. 2017;14(1):31. 10.1186\/s12954-017-0159-9.","journal-title":"Harm Reduct J"},{"issue":"1","key":"ref31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12954-022-00663-z","article-title":"The challenges, opportunities and strategies of engaging young people who use drugs in harm reduction: insights from young people with lived and living experience","volume":"19","author":"Stowe MJ","year":"2022","unstructured":"Stowe MJ, Feher O, Vas B, Kayastha S, Greer A. The challenges, opportunities and strategies of engaging young people who use drugs in harm reduction: insights from young people with lived and living experience. Harm Reduct J. 2022;19(1):83. 10.1186\/s12954-022-00663-z.","journal-title":"Harm Reduct J"},{"issue":"1","key":"ref32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13011-022-00502-1","article-title":"School-based harm reduction with adolescents: a pilot study","volume":"17","author":"Fischer NR","year":"2022","unstructured":"Fischer NR. School-based harm reduction with adolescents: a pilot study. Subst Abuse Treat Prev Policy. 2022;17(1):79. 10.1186\/s13011-022-00502-1.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"1","key":"ref33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/nyas.14922","article-title":"Punitive school discipline as a mechanism of structural marginalization with implications for health inequity: A systematic review of quantitative studies in the health and social sciences literature","volume":"1519","author":"Duarte CD","year":"2023","unstructured":"Duarte CD, Moses C, Brown M, Kajeepeta S, Prins SJ, Scott J, et al. Punitive school discipline as a mechanism of structural marginalization with implications for health inequity: A systematic review of quantitative studies in the health and social sciences literature. Ann N Y Acad Sci. 2023;1519(1):129\u201352. 10.1111\/nyas.14922.","journal-title":"Ann N Y Acad Sci"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"111270","DOI":"10.1016\/j.drugalcdep.2024.111270","article-title":"Does source matter? Examining the effects of health experts, friends, and social media influencers on young adult perceptions of Instagram e-cigarette education messages","volume":"258","author":"Lee DN","year":"2024","unstructured":"Lee DN, Liu J, Stevens H, Oduguwa K, Stevens EM. Does source matter? Examining the effects of health experts, friends, and social media influencers on young adult perceptions of Instagram e-cigarette education messages. Drug Alcohol Depend. 2024;258:111270. 10.1016\/j.drugalcdep.2024.111270.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"ref35","doi-asserted-by":"publisher","first-page":"e195183","DOI":"10.1001\/jamapediatrics.2019.5183","article-title":"Receipt of Addiction Treatment After Opioid Overdose Among Medicaid-Enrolled Adolescents and Young Adults","volume":"174","author":"Alinsky RH","year":"2020","unstructured":"Alinsky RH, Zima BT, Rodean J, Matson PA, Larochelle MR, Adger H Jr., et al. Receipt of Addiction Treatment After Opioid Overdose Among Medicaid-Enrolled Adolescents and Young Adults. JAMA Pediatr. 2020;174(3):e195183. 10.1001\/jamapediatrics.2019.5183.","journal-title":"JAMA Pediatr"},{"issue":"22","key":"ref36","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1001\/jama.2023.6266","article-title":"Treatments Used Among Adolescent Residential Addiction Treatment Facilities in the US, 2022","volume":"329","author":"King C","year":"2023","unstructured":"King C, Beetham T, Smith N, Englander H, Hadland SE, Bagley SM, et al. Treatments Used Among Adolescent Residential Addiction Treatment Facilities in the US, 2022. JAMA. 2023;329(22):1983\u20135. 10.1001\/jama.2023.6266.","journal-title":"JAMA"},{"issue":"3","key":"ref37","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jadohealth.2020.12.129","article-title":"Medicine. Medication for Adolescents and Young Adults With Opioid Use Disorder","volume":"68","author":"Society for Adolescent H","year":"2021","unstructured":"Society for Adolescent H. Medicine. Medication for Adolescents and Young Adults With Opioid Use Disorder. J Adolesc Health. 2021;68(3):632\u20136. 10.1016\/j.jadohealth.2020.12.129.","journal-title":"J Adolesc Health"},{"key":"ref38","unstructured":"Oregon Health Authority. Youth and Young Adult Substance Use Prevention, Treatment, and Recovery. 2023."},{"key":"ref39","volume-title":"Oregon Substance Use Disorder Services Inventory and Gap Analysis. OHSU-PSU School of Public Health, Oregon Health and Science University","author":"Lenahan K","year":"2022","unstructured":"Lenahan K, Rainer S, Baker R, Goren R, Waddell EN. Oregon Substance Use Disorder Services Inventory and Gap Analysis. OHSU-PSU School of Public Health, Oregon Health and Science University. Oregon Health Authority & Oregon Alcohol and Drug Policy Commission; 2022."},{"issue":"5","key":"ref40","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.jadohealth.2024.07.024","article-title":"The Changing Landscape of Adolescent and Young Adult Substance Use","volume":"75","author":"Bell LA","year":"2024","unstructured":"Bell LA, Hadland SE. The Changing Landscape of Adolescent and Young Adult Substance Use. J Adolesc Health. 2024;75(5):706\u20138. 10.1016\/j.jadohealth.2024.07.024.","journal-title":"J Adolesc Health"},{"key":"ref41","author":"Green E","year":"2023","unstructured":"Green E. State inaction left Oregon teens vulnerable to fentanyl\u2019s fatal spread. In: Report TL, editor.2023."},{"key":"ref42","volume-title":"Opioid Overdose Public Health Surveillance Update April 25th, 2024","author":"Oregon Health Authority","year":"2024","unstructured":"Oregon Health Authority. Opioid Overdose Public Health Surveillance Update April 25th, 2024. Oregon: Oregon Health Authority; 2024."},{"key":"ref43","unstructured":"Office of Juvenile Justice and Delinquency Prevention. Advise and Advance: Elevating the Youth Voice Through Youth Advisory Boards. 2023."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8534564\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8534564\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:09:10Z","timestamp":1776726550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8534564\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":43,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-8534564\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,2,13]]},"subtype":"preprint"}}